Landmark trials of medicine, told in a single sentence.
26 infectious diseases trials in 13 topics.
Topics in infectious diseases
HIV
Treatment-as-prevention (HPTN 052), universal ART (START), U=U (PARTNER) and long-acting injectable PrEP (HPTN 083).Antibiotic duration
Short courses in intra-abdominal infection (STOP-IT), Gram-negative bacteraemia (Yahav) and bloodstream infection (BALANCE).Clostridioides difficile
Fidaxomicin vs. vancomycin (Louie), faecal microbiota transplantation (van Nood) and bezlotoxumab (MODIFY).Tuberculosis
4-month regimen for drug-susceptible TB (Study 31) and 6-month BPaL/BPaLM for MDR-TB (ZeNix, TB-PRACTECAL).Antifungal therapy
Echinocandins for candidaemia (Reboli), voriconazole for aspergillosis (Herbrecht) and single-dose L-AmB for cryptococcosis (AMBITION-cm).Bloodstream infections
MRSA bacteraemia combination therapy (CAMERA2) and ESBL bloodstream infection (MERINO).Respiratory viruses
Baloxavir for influenza (CAPSTONE-1) and nirsevimab for RSV in infants (MELODY).Sepsis & septic shock
Resuscitation strategy (Rivers, ProCESS, CLOVERS), corticosteroids (APROCCHSS, ADRENAL) and adjuncts (LOVIT).Community-acquired pneumonia
Hydrocortisone for severe CAP (CAPE COD) and short-course antibiotics (Uranga).HAP / VAP
8 vs. 15 days of antibiotics for ventilator-associated pneumonia (Chastre).Infective endocarditis
Oral step-down therapy for stable left-sided endocarditis (POET).COVID-19
Dexamethasone in hospitalised COVID-19 (RECOVERY) and nirmatrelvir-ritonavir in outpatients (EPIC-HR).Bacterial meningitis
Adjunctive dexamethasone in suspected community-acquired bacterial meningitis (de Gans).
In 17,187 patients with suspected acute myocardial infarction, aspirin plus intravenous streptokinase reduced 5-week vascular mortality compared with placebo.